Risk assessment and management of atrial fibrillation patients with left atrial thrombus.

ANTICOAGULANTS; ATRIAL fibrillation diagnosis; ATRIAL fibrillation treatment; THROMBOEMBOLISM risk factors; THROMBOSIS risk factors; THROMBOEMBOLISM; DRUG therapy; WARFARIN; STROKE risk factors; STROKE prevention; COMPUTED tomography; CREATININE; ELECTRIC countershock; MAGNETIC resonance imaging; PEPTIDE hormones; RISK assessment; SERIAL publications; TRANSESOPHAGEAL echocardiography; DISEASE management; INTERNATIONAL normalized ratio; LEFT heart atrium; DIAGNOSIS

The article presents a case study of a Patients with atrial fibrillation (AF), at high risk of thrombus formation, in the left atrium (LA) and left atrial appendage (LAA), leading to stroke and systemic embolism. It mentions the distribution of clinical and demographic characteristics among patients with and without left atrial thrombus (LAT); and examines the resolution rate after 6weeks treatment was 41.5 percent and resolved or reduced thrombus was identified in 60.4 percent of patients.